Business · 18/07/2017Updated: 10/17/2026 · 1 min read
FDA Corrects Notice on Withdrawal of Drug Approval
Summary
The US Food and Drug Administration (FDA) has corrected a notice that incorrectly announced the withdrawal of approval for 44 new drug applications and 158 abbreviated new drug applications, including two specific ANDAs for Pindolol Tablets and Hydrocortisone Acetate Ophthalmic Ointment USP, which remain in effect.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →